Literature DB >> 8282828

Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology.

B T Colvin, S J Machin, T W Barrowcliffe, M Greaves, C A Ludlam, I J Mackie, F E Preston, P E Rose, I D Walker, A H Waters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8282828      PMCID： PMC501711          DOI： 10.1136/jcp.46.12.1069

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  Guidance on guidelines.

Authors:  A Haines; G Feder
Journal:  BMJ       Date:  1992-10-03

Review 2.  Oral anticoagulant drugs.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

3.  Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society.

Authors: 
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

4.  Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

Authors:  J N Saour; J O Sieck; L A Mamo; A S Gallus
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245
  4 in total
  2 in total

1.  Audit of anticoagulant therapy.

Authors:  P E Rose
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

2.  Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic.

Authors:  A S Radley; J Hall; M Farrow; P J Carey
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.